SMS Pharmaceuticals Ltd (SMSPHARMA)


πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 248.04
% Change: 2.07% (Prev Close: 243.00)

Volume: 1,41,523
% Change: -38.65% (Prev Volume: 2,30,665)

Delivery: 67,055
Delivery % : 47.38
% Change: -34.87% (Prev Delivery: 1,02,948)

Turnover: 353 Lacs
% Change: -37.73% (Prev Turnover: 567)

πŸ’Ή EOD Valuation

P/E Ratio: 30.66
P/B Ratio: 3.27
Market Cap: 2200 Rs. Cr.



Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: SMSPHARMA
Market Cap: 2100 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 398.00
52 Week Low: 175.00

All-Time High: 398.00 Rs.
All-Time Low: 6.25 Rs.


Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
5.72% | -4.60% | 17.56% | -31.51% | 42.18%


πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 66.26%

Change (3Y | 1Y): 2.08% | 0.00%

Pledged %: 37.60%

FII Holding

FII Holding: 0.03%

Change (3Y | 1Y): -0.60% | -0.05%

DII Holding

DII Holding: 3.03%

Change (3Y | 1Y): 3.03% | 0.60%

Public Holding: 30.68%


🏦 Financial Strength

Debt to Equity: 0.46
Debt: 310.75 Rs. Cr.

Book Value: 75.92 Rs.
Current Ratio: 1.71
Interest Coverage: 5.84
Free Cash Flow: -41.61 Rs. Cr.


πŸ“ˆ Growth & Sales

Sales Growth: 10.29%

Sales Growth Qtr (YOY | QoQ):
19.22% | -21.01%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
13.70% | 14.62% | 10.29%


πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 24.42%

Profit Growth Qtr (YOY | QoQ):
11.51% | -11.69%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
15.88% | 0.17% | 24.42%


EPS Rs.

EPS (TTM): 8.09 Rs.

EPS Qtr (Last Year | Latest):
1.93 Rs. | 2.05 Rs.

EPS Annual (Last Annual | Annual March):
5.83 Rs. | 7.71 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
14.83% | -1.34%


Net Profit Rs. Cr.

Net Profit (TTM): 70.26 Rs. Cr.

Net Profit (Annual - March): 68.38 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
16.33| 20.62 | 18.21


EBITDA Rs. Cr.

EBITDA (Quarter): 39.45 Rs. Cr.
EBITDA (Previous Yr Ql): 34.84 Rs. Cr.

EBITDA (Annual - March): 146.20 Rs. Cr.
EBITDA (Previous Annual): 121.41 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
11.41% | 6.81%


πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 17.85%

OPM Qtr (Previous | Current):
16.66% | 19.82%

OPM Annual (5 Yrs | Last Yr | March):
17.68% | 16.49% | 17.88%


Return on Equity %

ROE: 11.00%

ROE (5 Yrs | 3 Yrs | Last Yr):
10.00% | 7.39% | 9.27%


Return on Capital Employed %

ROCE: 12.19%

ROCE (5 Yrs | 3 Yrs | Last Yr):
11.25% | 9.03% | 11.23%


Return on Assets %

ROA (TTM): 6.07%

ROA (5 Yrs | 3 Yrs | Last Yr):
5.56% | 3.84% | 4.98%



PEG Ratio: 175.76
Dividend Yield: 0.17%

PE 3 Yrs: 40.74
PE 5 Yrs: 29.49

Dividend Yield: 0.17%


πŸ‘₯ Company

SMS Pharmaceuticals Ltd

SMSPHARMA

Promoter Holding: %